Page 5 - RxExam's Naplex Theory Review Part-1
P. 5
www.pharmacyexam.com Krisman
Table of Contents
1. INOTROPIC AGENTS .................................................................................................................................. 6
2. ANTIARRHYTHMIC AGENTS ....................................................................................................................... 8
3. BETA BLOCKERS ....................................................................................................................................... 19
4. CENTRALLY ACTING ANTIHYPERTENSIVES .............................................................................................. 22
5. CA-CHANNEL BLOCKERS .......................................................................................................................... 25
6. ACE INHIBITORS ...................................................................................................................................... 32
7. VASODILATORS ....................................................................................................................................... 39
8. ANGINA ................................................................................................................................................... 44
9. DIURETICS ............................................................................................................................................... 55
10. SPECIFIC ALPHA-1 BLOCKERS ................................................................................................................ 64
11. ANTI-HYPERLIPIDEMIC AGENTS ............................................................................................................ 68
12. TRANQUILIZERS & NARCOLEPSY AGENTS ............................................................................................. 79
13. ANTIEPILEPTIC AGENTS ......................................................................................................................... 89
14. ANTIDEPRESSANTS .............................................................................................................................. 105
15. ANTIPARKINSON’S ............................................................................................................................... 126
16. ATTENTION DEFICIT HYPERACTIVITY DISORDER ................................................................................. 137
17. ANTIPSYCHOTICS ................................................................................................................................. 141
18. PENICILLIN ........................................................................................................................................... 154
19. CEPHALOSPORINS ............................................................................................................................... 161
20. ERYTHROMYCIN .................................................................................................................................. 170
21. AMINOGLYCOSIDES ............................................................................................................................. 177
22. SULFONAMIDES .................................................................................................................................. 182
23. QUINOLONES ...................................................................................................................................... 186
24. TETRACYCLINES ................................................................................................................................... 192
25. MISCELLANEOUS ANTIBACTERIAL AGENTS ......................................................................................... 196
26. ANTI-FUNGAL ...................................................................................................................................... 204
27. ANTI-VIRAL .......................................................................................................................................... 218
28. ANTI-TUBERCULOSIS ........................................................................................................................... 247
29. ANTI-NEOPLASTIC AGENTS ................................................................................................................. 256
4
